Mutations of the human SMC5/6 genome maintenance complex can lead to several genome instability syndromes and are associated with tumorigenesis. However, the molecular consequences of SMC5/6 deficiencies in human cells are only partly known, preventing a better understanding of disease-causing mechanisms. To address this issue, we employed the dTAG technology to induce rapid loss of SMC5 or SMC6 in a panel of human cell lines. While SMC5/6 depletion confers gradual cessation of cell proliferation in all tested cell lines, distinct molecular consequences are seen in p53-deficient verses -proficient cells. In p53-deficient HEK293A and HeLa cells or p53 knockout RPE1 cells, SMC5/6 depletion reveals a mitotic phenotype of increases in multipolar spindle and abnormal chromosome segregation. In contrast, in p53-proficient RPE1 and HCT116 cells, SMC5/6 loss favors G1 accumulation and thereby masking mitotic defects. The mitotic phenotype and cell proliferation defect caused by SMC5/6 loss is exacerbated by knockout of the BLM helicase, a tumor suppressor mutated in Bloom syndrome patients. In comparison, SMC5/6 did not show genetic interaction in cell proliferation assays with the MUS81 endo nuclease, the FANCM DNA helicase, or the PrimPol polymerase. Collectively, our data reveal that SMC5/6 is required to prevent multipolar spindle and associated mitotic defects in conjunction with BLM, thus providing new perspectives in understanding etiologies of diseases caused by their deficiencies.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: